Table 5.
Combinations of metals/related linker and their role in various biomedical applications.
Sr. no. | Metal ion | Organic linker | MOFs | Potential applications | References |
---|---|---|---|---|---|
1 | Zn | 2-Methylimidazole | ZIF-8 | Drug delivery (doxorubicin drug) | Vasconcelos et al., 2012 |
2 | Zr | 2-Aminoterephthalic acid | UiO-66 | Drug delivery (drug caffeine) | Nagata et al., 2015 |
3 | Zn | 1,1′,4′,1″,4″,1-Quaterphenyl-3,5,3,5-tetracarboxylic acid 1,3,5-benzenetrisbenzoate | (NH2(CH3)2[Zn3(L)2 · 3.5DMF]) | Drug delivery | Li Q. L., et al., 2015 |
4 | Cu | [1,1′;3′,1″] terphenyl-4,5′,4″-tricarboxylic acid) and pyrazine | [Cu3L2(pyrazine) (H2O)] | Drug delivery of ibuprofen | Wei et al., 2016 |
5 | Cu | 5-NH2-m-benzenedicarboxylate | MOP-15 | Drug delivery | Wang et al., 2011 |
6 | Fe3+ | 2-Amino terephthalic acid | Fe-MIL-53-NH2-FA-5-FAM/5-FU | MRI and optical bioimaging | Gao et al., 2017 |
7 | Gd3+ | 4-Dimethylaminopyridine | Gd-DTPA-FITC-CS11 | Bioimaging | Wang et al., 2016 |
8 | Zn | 2-Methylimidazole | Fe3O4@PAA/AuNCs/ZIF-8 nanoparticles | MRI and CT bioimaging | Bian et al., 2015 |
9 | Gd3+ | Ru[4,4′-(COOH)2bipyridyl(bpy)]3 | Gd-Ru MOFs | MRI and optical bioimaging | Huang et al., 2016 |
10 | Fe3+ | Fumarate | Au@MIL-88(A) | CT bioimaging | Shang et al., 2017 |
11 | Cu | H3btc | Cu-BTC(MOF-199) | Antibacterial application | Rodríguez et al., 2014 |
12 | Co | H8 tdm: tetrakis [(3,5-dicarboxyphenyl)-oxamethyl] methane | Co-TDM | Highly effective bactericidal activities application | Zhuang et al., 2012 |
13 | Ag | HO-H2ipa = 5-hydroxyisophthalic acid and H2pydc = pyridine-3, 5-dicarboxylic acid | Ag2(O-IPA)(H2O)·(H3O) and Ag5(PYDC)2(OH) | Antibacterial application | Indumathy et al., 2007 |
14 | Zn | — | Bio-MOF-100 | Drug loading and release for immobilization of biomolecules | An et al., 2012 |
15 | Mg | H4gal | Mg(H4gal) | Antioxidant carrier application | Hidalgo et al., 2017 |
16 | Zn | AzA: azelaic acid | BioMIL-5 | Antibacterial application | Tamames-Tabar et al., 2015 |